annual FCF:
-$89.59M+$33.40M(+27.16%)Summary
- As of today (September 15, 2025), TARS annual free cash flow is -$89.59 million, with the most recent change of +$33.40 million (+27.16%) on December 31, 2024.
- During the last 3 years, TARS annual FCF has fallen by -$92.76 million (-2933.46%).
- TARS annual FCF is now -2933.46% below its all-time high of $3.16 million, reached on December 31, 2021.
Performance
TARS Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$30.39M-$9.15M(-43.06%)Summary
- As of today (September 15, 2025), TARS quarterly free cash flow is -$30.39 million, with the most recent change of -$9.15 million (-43.06%) on June 30, 2025.
- Over the past year, TARS quarterly FCF has dropped by -$14.95 million (-96.78%).
- TARS quarterly FCF is now -247.98% below its all-time high of $20.54 million, reached on June 30, 2021.
Performance
TARS quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$87.82M-$14.95M(-20.51%)Summary
- As of today (September 15, 2025), TARS TTM free cash flow is -$87.82 million, with the most recent change of -$14.95 million (-20.51%) on June 30, 2025.
- Over the past year, TARS TTM FCF has increased by +$41.66 million (+32.18%).
- TARS TTM FCF is now -1669.84% below its all-time high of $5.59 million, reached on September 30, 2021.
Performance
TARS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
TARS Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.2% | -96.8% | +32.2% |
| 3 y3 years | -2933.5% | -593.6% | -248.0% |
| 5 y5 years | -2228.3% | - | - |
TARS Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2933.5% | +27.2% | -593.6% | +22.8% | -248.0% | +36.7% |
| 5 y | 5-year | -2933.5% | +27.2% | -248.0% | +22.8% | -1669.8% | +36.7% |
| alltime | all time | -2933.5% | +27.2% | -248.0% | +22.8% | -1669.8% | +36.7% |
TARS Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$30.39M(+43.1%) | -$87.82M(+20.5%) |
| Mar 2025 | - | -$21.24M(-22.1%) | -$72.87M(-18.7%) |
| Dec 2024 | -$89.59M(-27.2%) | -$27.25M(+205.1%) | -$89.59M(-11.9%) |
| Sep 2024 | - | -$8.93M(-42.1%) | -$101.67M(-21.5%) |
| Jun 2024 | - | -$15.44M(-59.3%) | -$129.48M(-6.6%) |
| Mar 2024 | - | -$37.96M(-3.5%) | -$138.65M(+12.7%) |
| Dec 2023 | -$123.00M(+148.3%) | -$39.34M(+7.1%) | -$123.00M(+29.9%) |
| Sep 2023 | - | -$36.74M(+49.3%) | -$94.66M(+23.5%) |
| Jun 2023 | - | -$24.61M(+10.3%) | -$76.63M(+35.9%) |
| Mar 2023 | - | -$22.31M(+102.8%) | -$56.40M(+13.9%) |
| Dec 2022 | -$49.54M | -$11.00M(-41.2%) | -$49.54M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$18.71M(+327.0%) | -$50.93M(+101.8%) |
| Jun 2022 | - | -$4.38M(-71.6%) | -$25.23M(+7884.8%) |
| Mar 2022 | - | -$15.45M(+24.6%) | -$316.00K(-110.0%) |
| Dec 2021 | $3.16M(-114.6%) | -$12.39M(-277.3%) | $3.16M(-43.5%) |
| Sep 2021 | - | $6.99M(-66.0%) | $5.59M(-500.4%) |
| Jun 2021 | - | $20.54M(-271.6%) | -$1.40M(-93.6%) |
| Mar 2021 | - | -$11.97M(+20.1%) | -$21.93M(+82.8%) |
| Dec 2020 | -$21.59M(+461.2%) | -$9.96M(+390.3%) | -$11.99M(+490.3%) |
| Mar 2020 | - | -$2.03M | -$2.03M |
| Dec 2019 | -$3.85M(+223.4%) | - | - |
| Dec 2018 | -$1.19M | - | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual free cash flow?
- What is the all time high annual FCF for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual FCF year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly FCF year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. TTM FCF year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual free cash flow?
The current annual FCF of TARS is -$89.59M
What is the all time high annual FCF for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual free cash flow is $3.16M
What is Tarsus Pharmaceuticals, Inc. annual FCF year-on-year change?
Over the past year, TARS annual free cash flow has changed by +$33.40M (+27.16%)
What is Tarsus Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly FCF of TARS is -$30.39M
What is the all time high quarterly FCF for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly free cash flow is $20.54M
What is Tarsus Pharmaceuticals, Inc. quarterly FCF year-on-year change?
Over the past year, TARS quarterly free cash flow has changed by -$14.95M (-96.78%)
What is Tarsus Pharmaceuticals, Inc. TTM free cash flow?
The current TTM FCF of TARS is -$87.82M
What is the all time high TTM FCF for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high TTM free cash flow is $5.59M
What is Tarsus Pharmaceuticals, Inc. TTM FCF year-on-year change?
Over the past year, TARS TTM free cash flow has changed by +$41.66M (+32.18%)